The Benefits of Tablet Tooling Standardization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Benefits of Tablet Tooling Standardization
A single, global tooling standard would offer many benefits, but one has been slow to emerge.


Pharmaceutical Technology
Volume 35, Issue 3, pp. 152-153

Clearances and tolerances

Unlike typical mechanical processes, powder compaction inevitably results in granule coming between the lower punch tip and die bore, resulting in resistance. Consideration should be given to the clearance between such surfaces.


Figure 3: Clearances and tolerances.
Lower punch tip to die bore clearance. Clearances and tolerances (see Figure 3) are critical to ensure accurate functionality of the tooling, and reduce wear of tooling and press components. The clearances between the punch tips and die bores are important to ensure good, problemfree tablets and to eliminate problems such as capping (see Figure 4). The ISO standard stipulates the use of DIN Norm for tolerances, adopting the same size and clearance for both upper and lower punches irrespective of tablet size. This also creates a wider variation in clearance between the lower punch tip and die bore regardless of granule size, which can cause granule leakage past the lower tip, resulting in potential wear and damage to tooling and press parts.


Figure 4: A typical example of capping.
Upper punch tip to die bore clearance. ISO adoption of DIN Norm on upper punches also results in insufficient clearance leading to rejected tablets through capping. To counter this, all dies have to be tapered at both ends to enable air to escape from the tablet. This requirement increases tooling costs for the tablet manufacturer.

The Eurostandard and the TSM standard avoid these issues by adopting customized clearances, which offer advantages over ISO standards, although there are differences between the two. The Eurostandard adopts a tighter clearance range to help improve general operation and product yield.

Conclusion

Although there are other small variations between the standards, such as seal groove configuration, these variations do not prevent interchangeability and are not detrimental to the running of the tablet press. All of these differences are surmountable.

In recognition of the need to eliminate these variables and specifically take into account the sensible and efficient provisions for cross-platform/press compatibility laid out in ISO 18084, the Eurostandard has been updated to make it compatible with the ISO standard.

A single global tooling standard should be highly desirable for the industry; however, even if tablet press manufacturers could be convinced that it is in their commercial interest to adopt it, it will take time for these changes to evolve. Leading tablet-press manufacturers are always seeking to innovate and move the industry forward so tooling standards will always require revision.

In turn, this means that highquality tooling suppliers will always need to retain the ability to solve complex problems and preserve the skill set within their workforce to manufacture tooling that is compatible with any press worldwide.

In conclusion, I believe that calls for the standards laid out in ISO 18084:2005(E) to be adopted globally should be fully endorsed. However, I also believe that the Eurostandard already represents a comprehensive global standard because it is the most widely adopted tabletting tooling standard today and is compatible with ISO.

Steve Deakin is business development director at I Holland,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here